MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.38
-0.28
-1.68%
After Hours: 16.38 0 0.00% 16:00 07/23 EDT
OPEN
16.80
PREV CLOSE
16.66
HIGH
16.90
LOW
15.88
VOLUME
88.35K
TURNOVER
--
52 WEEK HIGH
28.96
52 WEEK LOW
15.88
MARKET CAP
607.87M
P/E (TTM)
-26.8613
1D
5D
1M
3M
1Y
5Y
Akoya to Report Second Quarter 2021 Financial Results on August 10, 2021
MARLBOROUGH, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the second quarter of 2021 after the market close on Tuesday, A...
GlobeNewswire · 4d ago
Akoya Highlights Publication Of MITRE Study In The Journal For ImmunoTherapy Of Cancer
Akoya Biosciences, Inc., (NASDAQ:AKYA) The Spatial Biology Company®, today announced that the Phenoptics™ mIF solution was used in a multi-site study to demonstrate and validate an automated end-to-end workflow
Benzinga · 5d ago
Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial Biology Workflow, in the Journal for ImmunoTherapy of Cancer
Results from the study provide evidence of standardization of an automated spatial biology workflow, based on the company’s Phenoptics™ multiplex immunofluorescence (mIF) platform, for clinical and translational research MITRE Reproducibility Study The MIT...
GlobeNewswire · 5d ago
What Type Of Shareholders Own The Most Number of Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares?
If you want to know who really controls Akoya Biosciences, Inc. ( NASDAQ:AKYA ), then you'll have to look at the makeup...
Simply Wall St. · 07/16 05:16
64 Biggest Movers From Yesterday
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday.
Benzinga · 07/14 08:50
Akoya picks CrestOptics for spatial biology collaboration
Akoya Biosciences ([[AKYA]] +5.1%) and CrestOptics S.p.A have entered into a collaboration agreement to jointly develop new spatial biology and spatial phenotyping applications.The collaboration aims to provide new workflows, faster acquisition
Seekingalpha · 06/29 15:40
CrestOptics Selected by Akoya Biosciences for Spatial Biology Collaboration
CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced that it has been selected by Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Compan...
Business Wire · 06/29 15:30
Akoya Biosciences Says To Partner With Nikon, CrestOptics And Andor
Akoya Biosciences Inc., (NASDAQ:AKYA) The Spatial Biology Company®, today announced partnerships with premier microscope providers, Nikon, CrestOptics, and Andor to enable the development of new spatial biology
Benzinga · 06/29 12:08
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AKYA. Analyze the recent business situations of Akoya Biosciences, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AKYA stock price target is 26.33 with a high estimate of 28.00 and a low estimate of 25.00.
EPS
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 37.11M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.12%
Healthcare Equipment & Supplies
+1.14%
Key Executives
President
Terry Lo
Chief Executive Officer
Brian McKelligon
Chief Financial Officer/Primary Contact
Joe Driscoll
Vice President - Operations
Seth Benson
Vice President - Research & Development
Peter Miller
Director
Thomas Schnettler
Director
Matthew Winkler
Independent Director
Scott Mendel
No Data
  • All
  • Financials
  • Insiders
More
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company. The Company provides spatial biology solutions. Through its Co-Detection by indEXing (CODEX) and Phenoptics platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the continuum, from discovery through translational and clinical research. CODEX is a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition. It provides a comprehensive spatial biology solution, converting its customer’s standard fluorescent microscope into an automated imaging system to produce ultra-high parameter multiplex images capable of providing in situ analysis at the cellular and subcellular scales. Its Phenoptics platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or FFPE tissue sections and tissue microarrays (TMAs) utilizing an automated and high-throughput workflow.

Webull offers kinds of Akoya Biosciences Inc stock information, including NASDAQ:AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.